LFG
IMNM icon

Larson Financial Group’s Immunome IMNM Stock Holding History

Larson Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Sell
70
-15
-18% -$321 ﹤0.01% 3197
2026
Q1 		$1.86K Buy
85
+2
+2% +$45 ﹤0.01% 2978
2025
Q4 		$1.78K Sell
83
-7
-8% -$123 ﹤0.01% 2805
2025
Q3 		$1.05K Buy
90
+23
+34% +$229 ﹤0.01% 2905
2025
Q2 		$623 Buy
+67
New +$549 ﹤0.01% 2798

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Larson Financial Group's IMNM Position: Q2 2026 in Review

Larson Financial Group reduced its Immunome (IMNM) stake by 18% in Q2 2026, selling an estimated $321 and leaving 70 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #3197.

Larson Financial Group first reported a position in IMNM in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.86K in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Larson Financial Group held 70 shares of Immunome worth $1.48K as of Q2 2026.
  • Larson Financial Group sold 15 Immunome shares in Q2 2026, an estimated $321.
  • Immunome made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3197 holding.
  • Larson Financial Group first reported a position in Immunome in Q2 2025 and has held it in 5 quarters since.
  • Larson Financial Group's Immunome position peaked at $1.86K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.